Good morning :)
Place Order
Add to Watchlist

Genomic Valley Biotech Ltd

GVBL Share Price

50.501.21% (-0.62)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹15 cr, stock is ranked 4,415

Stock is 3.16x as volatile as Nifty

GVBL Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹15 cr, stock is ranked 4,415

Stock is 3.16x as volatile as Nifty

GVBL Performance & Key Metrics

GVBL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
44.074.36
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.596.400.79%

GVBL Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GVBL Company Profile

Genomic Valley Biotech Ltd is conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market

GVBL Similar Stocks (Peers)

Compare with peers Compare with peers 

GVBL Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
49.05
49.05
1Y Return
4.10%
4.10%
Buy Reco %
73.33
73.33
PE Ratio
-1,270.92
-1,270.92
1Y Return
16.61%
16.61%
Buy Reco %
100.00
100.00
PE Ratio
95.98
95.98
1Y Return
2.41%
2.41%
Buy Reco %
66.67
66.67
PE Ratio
58.51
58.51
1Y Return
66.03%
66.03%
Buy Reco %
100.00
100.00
PE Ratio
-298.57
-298.57
1Y Return
193.21%
193.21%
Buy Reco %
0.00
0.00
Compare with Peers

GVBL Forecast

GVBL Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GVBL

GVBL

Income

Balance Sheet

Cash Flow

GVBL Income Statement

GVBL Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -0.23%, vs industry avg of 21.18%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.01% to 0%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 4.42%, vs industry avg of 20.36%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue0.520.621.000.860.210.572.760.170.850.85
Raw Materialssubtract0.000.000.000.000.000.001.580.000.400.41
Power & Fuel Costsubtract0.010.010.050.020.000.010.000.00
Employee Costsubtract0.250.340.270.180.090.140.150.04
Selling & Administrative Expensessubtract0.100.090.140.090.080.130.090.11
Operating & Other expensessubtract0.180.050.11-0.000.180.170.28-0.00
Depreciation/Amortizationsubtract0.040.080.190.180.190.080.010.000.00
Interest & Other Itemssubtract0.000.000.000.180.180.040.000.000.00
Taxes & Other Itemssubtract0.000.020.00-0.080.060.010.000.000.090.09
EPS-0.200.100.790.95-1.87-0.032.130.071.171.15
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

GVBL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

GVBL Stock Peers

GVBL Past Performance & Peer Comparison

GVBL Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Genomic Valley Biotech Ltd42.854.36
Biocon Ltd49.051.970.30%
Onesource Specialty Pharma Ltd-1,270.9257.68
Sai Life Sciences Ltd95.9816.75

GVBL Stock Price Comparison

Compare GVBL with any stock or ETF
Compare GVBL with any stock or ETF
GVBL
Loading...

GVBL Holdings

GVBL Shareholdings

GVBL Promoter Holdings Trend

GVBL Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 7.89%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GVBL Institutional Holdings Trend

GVBL Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GVBL Shareholding Pattern

GVBL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding46.78%0.00%0.00%0.00%53.22%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GVBL Shareholding History

GVBL Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

GVBL Insider Trades & Bulk Stock Deals

GVBL Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing GVBL stock

smallcases containing GVBL stock

Looks like this stock is not in any smallcase yet.

GVBL Events

GVBL Events

GVBL Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GVBL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

GVBL Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GVBL has not given any dividends in last 5 years

GVBL Dividends

GVBL Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GVBL Stock News & Opinions

GVBL Stock News & Opinions

Earnings
Genomic Valley Biotech reports standalone net loss of Rs 0.08 crore in the March 2025 quarter

Net Loss of Genomic Valley Biotech reported to Rs 0.08 crore in the quarter ended March 2025 as against net loss of Rs 0.04 crore during the previous quarter ended March 2024. Sales reported to Rs 0.26 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024. For the full year,net profit rose 1700.00% to Rs 0.36 crore in the year ended March 2025 as against Rs 0.02 crore during the previous year ended March 2024. Sales rose 394.12% to Rs 0.84 crore in the year ended March 2025 as against Rs 0.17 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.260 0 0.840.17 394 OPM %3.850 -53.5711.76 - PBDT0.01-0.04 LP 0.450.02 2150 PBT0.01-0.04 LP 0.450.02 2150 NP-0.08-0.04 -100 0.360.02 1700 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Genomic Valley Biotech announces board meeting date

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Genomic Valley Biotech standalone net profit rises 700.00% in the December 2024 quarter

Net profit of Genomic Valley Biotech rose 700.00% to Rs 0.16 crore in the quarter ended December 2024 as against Rs 0.02 crore during the previous quarter ended December 2023. Sales rose 450.00% to Rs 0.22 crore in the quarter ended December 2024 as against Rs 0.04 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.220.04 450 OPM %72.7350.00 - PBDT0.160.02 700 PBT0.160.02 700 NP0.160.02 700 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Genomic Valley Biotech schedules AGM

Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on 30 December 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 6 December 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter ended September 2023. Sales rose 200.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.210.07 200 OPM %66.6728.57 - PBDT0.150.02 650 PBT0.150.02 650 NP0.150.02 650 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Genomic Valley Biotech standalone net profit rises 333.33% in the June 2024 quarter

11 months agoBusiness Standard
Earnings
Genomic Valley Biotech standalone net profit rises 333.33% in the June 2024 quarter

Net profit of Genomic Valley Biotech rose 333.33% to Rs 0.13 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales rose 166.67% to Rs 0.16 crore in the quarter ended June 2024 as against Rs 0.06 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.160.06 167 OPM %81.2550.00 - PBDT0.130.03 333 PBT0.130.03 333 NP0.130.03 333 Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Genomic Valley Biotech Ltd (GVBL) today?

    The share price of GVBL as on 10th July 2025 is ₹50.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Genomic Valley Biotech Ltd (GVBL) share?

    The past returns of Genomic Valley Biotech Ltd (GVBL) share are
    • Past 1 week: 4.43%
    • Past 1 month: 6.61%
    • Past 3 months: -12.93%
    • Past 6 months: -41.14%
    • Past 1 year: 17.44%
    • Past 3 years: 47.88%
    • Past 5 years: 242.61%

  3. What are the peers or stocks similar to Genomic Valley Biotech Ltd (GVBL)?
  4. What is the market cap of Genomic Valley Biotech Ltd (GVBL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genomic Valley Biotech Ltd (GVBL) is ₹15.43 Cr as of 10th July 2025.

  5. What is the 52 week high and low of Genomic Valley Biotech Ltd (GVBL) share?

    The 52-week high of Genomic Valley Biotech Ltd (GVBL) is ₹108.15 and the 52-week low is ₹39.52.

  6. What is the PE and PB ratio of Genomic Valley Biotech Ltd (GVBL) stock?

    The P/E (price-to-earnings) ratio of Genomic Valley Biotech Ltd (GVBL) is 42.85. The P/B (price-to-book) ratio is 4.36.

  7. Which sector does Genomic Valley Biotech Ltd (GVBL) belong to?

    Genomic Valley Biotech Ltd (GVBL) belongs to the Health Care sector & Biotechnology sub-sector.

  8. How to buy Genomic Valley Biotech Ltd (GVBL) shares?

    You can directly buy Genomic Valley Biotech Ltd (GVBL) shares on Tickertape. Simply sign up, connect your demat account and place your order.